High Incidence of Undiagnosed Hepatocellular Carcinoma in Transplant Recipients With Metabolic‐Associated Steatotic Liver Disease

Patients with metabolic liver disease may be at higher risk of u-HCC compared to other etiologies of liver disease despite regular, contrast-enhanced, cross-sectional imaging. One possible explanation for this is the difficulty of HCC detection in metabolic liver disease, as demonstrated by greater likelihood of inter-reader discordance in imaging assessment in these patients. KEYWORDS (INDEX MEDICUS).